The cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury

Archive ouverte

Bignon, Yohan | Poindessous, Virginie | Lazareth, Hélène | Passet, Bruno, B. | Vilotte, Jean-Luc | Djouadi, Fatima | Mouillet-Richard, Sophie | Pallet, Nicolas

Edité par CCSD ; Nature Publishing Group -

International audience. Endoplasmic Reticulum (ER) stress underlies the pathogenesis of numerous kidney diseases. A better care of patients with kidney disease involves the identification and validation of ER stress biomarkers in the early stages of kidney disease. For the first time to our knowledge, we demonstrate that the prion protein PrP C is secreted in a conventional manner by ER-stressed renal epithelial cell under the control of the transcription factor x-box binding protein 1 (XBP1) and can serve as a sensitive urinary biomarker for detecting tubular ER stress. Urinary PrP C elevation occurs in patients with chronic kidney disease. In addition, in patients undergoing cardiac surgery, detectable urine levels of PrP C significantly increase after cardiopulmonary bypass, a condition associated with activation of the IRE1-XBP1 pathway in the kidney. In conclusion, our study has identified PrP C as a novel urinary ER stress biomarker with potential utility in early diagnosis of ongoing acute or chronic kidney injury.

Consulter en ligne

Suggestions

Du même auteur

Cellular prion protein dysfunction in a prototypical inherited metabolic myopathy

Archive ouverte | Boufroura, Fatima-Zohra | CCSD

International audience. Inherited fatty acid oxidation diseases in their mild forms often present as metabolic myopathies. Carnitine Palmitoyl Transferase 2 (CPT2) deficiency, one such prototypical disorder is assoc...

Cell stress response impairs de novo NAD+ biosynthesis in the kidney

Archive ouverte | Bignon, Yohan | CCSD

International audience. The biosynthetic routes leading to de novo Nicotinamine Adenine Dinucleotide (NAD+) production are involved in acute kidney injury (AKI) with a critical role for Quinolinate Phosphoribosyl Tr...

Renal Function Decline Under Therapy With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria

Archive ouverte | Lazareth, Hélène | CCSD

International audience. Introduction: Givosiran is an RNA interference therapeutic designed to block the synthesis of the aminolevulinic acid (ALA) synthase 1 (ALAS1) enzyme in patients with acute intermittent porph...

Chargement des enrichissements...